138 related articles for article (PubMed ID: 22015022)
21. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks.
Poon LC; Chelemen T; Minekawa R; Frisova V; Nicolaides KH
Am J Obstet Gynecol; 2009 May; 200(5):508.e1-6. PubMed ID: 19285649
[TBL] [Abstract][Full Text] [Related]
22. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
Spencer K; Cowans NJ
J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
[TBL] [Abstract][Full Text] [Related]
23. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.
Audibert F; Boucoiran I; An N; Aleksandrov N; Delvin E; Bujold E; Rey E
Am J Obstet Gynecol; 2010 Oct; 203(4):383.e1-8. PubMed ID: 20691410
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal determination of serum placental protein 13 during development of preeclampsia.
Huppertz B; Sammar M; Chefetz I; Neumaier-Wagner P; Bartz C; Meiri H
Fetal Diagn Ther; 2008; 24(3):230-6. PubMed ID: 18753763
[TBL] [Abstract][Full Text] [Related]
25. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome.
Poon LC; Chelemen T; Granvillano O; Pandeva I; Nicolaides KH
Obstet Gynecol; 2008 Nov; 112(5):1082-90. PubMed ID: 18978109
[TBL] [Abstract][Full Text] [Related]
26. Extravillous trophoblast-associated ADAM12 exerts pro-invasive properties, including induction of integrin beta 1-mediated cellular spreading.
Biadasiewicz K; Fock V; Dekan S; Proestling K; Velicky P; Haider S; Knöfler M; Fröhlich C; Pollheimer J
Biol Reprod; 2014 May; 90(5):101. PubMed ID: 24695627
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity and specificity of placental proteins for gestational age screening: An exploratory study.
Raymond EG; Frye LJ; Weaver MA; Lebed JP; Ren X; Steider E; Winikoff B; Barnhart KT
Contraception; 2020 May; 101(5):309-314. PubMed ID: 32014519
[TBL] [Abstract][Full Text] [Related]
28. Association between physical activity in early pregnancy and markers of placental growth and function.
Ferland S; Bujold E; Giguère Y; Girard M; Demers S; Forest JC
J Obstet Gynaecol Can; 2013 Sep; 35(9):787-792. PubMed ID: 24099443
[TBL] [Abstract][Full Text] [Related]
29. Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome in pregnancies at high risk of impaired placentation.
Herraiz I; López-Jiménez EA; García-Burguillo A; Nieto O; Villar OP; Escribano D; Galindo A
Ultrasound Obstet Gynecol; 2009 May; 33(5):518-23. PubMed ID: 19402101
[TBL] [Abstract][Full Text] [Related]
30. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
Bersinger NA; Ødegård RA
Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
[TBL] [Abstract][Full Text] [Related]
31. Repeated measures of placental growth factor, placental protein 13, and a disintegrin and metalloprotease 12 at first and second trimesters for preeclampsia screening.
Boucoiran I; Suarthana E; Rey E; Delvin E; Fraser WB; Audibert F
Am J Perinatol; 2013 Sep; 30(8):681-8. PubMed ID: 23386402
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional ultrasound measurement of the placental volume in early pregnancy: method and correlation with biochemical placenta parameters.
Metzenbauer M; Hafner E; Hoefinger D; Schuchter K; Stangl G; Ogris E; Philipp K
Placenta; 2001 Jul; 22(6):602-5. PubMed ID: 11440550
[TBL] [Abstract][Full Text] [Related]
33. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.
Cowans NJ; Spencer K; Meiri H
Prenat Diagn; 2008 Feb; 28(2):121-5. PubMed ID: 18186153
[TBL] [Abstract][Full Text] [Related]
34. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A.
Proctor LK; Toal M; Keating S; Chitayat D; Okun N; Windrim RC; Smith GC; Kingdom JC
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):274-82. PubMed ID: 19672838
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the impact of maternal smoking on ultrasound and endocrinological markers of first trimester placentation.
Jauniaux E; Suri S; Muttukrishna S
Early Hum Dev; 2013 Sep; 89(9):777-80. PubMed ID: 23845775
[TBL] [Abstract][Full Text] [Related]
36. Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies.
Akolekar R; Pérez Penco JM; Skyfta E; Rodríguez Calvo J; Nicolaides KH
Fetal Diagn Ther; 2010; 27(2):72-7. PubMed ID: 20332643
[TBL] [Abstract][Full Text] [Related]
37. ADAM12: a novel first-trimester maternal serum marker for Down syndrome.
Laigaard J; Sørensen T; Fröhlich C; Pedersen BN; Christiansen M; Schiøtt K; Uldbjerg N; Albrechtsen R; Clausen HV; Ottesen B; Wewer UM
Prenat Diagn; 2003 Dec; 23(13):1086-91. PubMed ID: 14691998
[TBL] [Abstract][Full Text] [Related]
38. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia.
Spencer K; Cowans NJ; Chefetz I; Tal J; Kuhnreich I; Meiri H
Prenat Diagn; 2007 Mar; 27(3):258-63. PubMed ID: 17278173
[TBL] [Abstract][Full Text] [Related]
39. Homodimeric pregnancy-associated plasma protein-A in normal human placenta of first and third trimester of pregnancy: biochemical and morphological observations.
D'Elia P; Marzioni D; Castellucci M; Mocci C; Pala A
Placenta; 2012 Nov; 33(11):942-5. PubMed ID: 23010598
[TBL] [Abstract][Full Text] [Related]
40. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
